Arbor Biotechnologies to Present at the Bank of America Global Healthcare Conference
CAMBRIDGE, MA – May 3, 2022 -
Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced its participation in the upcoming Bank of America Global Healthcare Conference in Las Vegas, NV.
Arbor’s CFO, Steven Favaloro and CTO, David Cheng will present a corporate overview in person on Tuesday, May 10, 2022 at 11:50 a.m. PDT (2:50 p.m. EDT).
A webcast of the presentation will be accessible through the News Section of the company’s website at www.arbio.bio, with a replay available for 90 days following the event.